Multidrug-resistant tuberculosis and diabetes mellitus as a problem of modern medicine

1. Al-Rifai RH, Pearson F, Critchley J, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2017;12: e0187967.10.1371/journal.pone.0187967569782529161276Search in Google Scholar

2. Syal K, Srinivasan A, Banerjee D. VDR, RXR, coronin-1 and inter-feron ɤ levels in PBMCs of type-2 diabetes patients: molecular link between diabetes and tuberculosis. Indian Journal of Clinical Biochemistry. 2015;30(3): 323–328.10.1007/s12291-014-0431-7446906426089620Search in Google Scholar

3. Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Zachariah R, Dlodlo RA. How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS? The International Journal of Tuberculosis and Lung Disease. 2018;22: 1117–1126.Search in Google Scholar

4. Koesoemadinata RC, Kranzer K, Livia R, Susilawati N, Annisa J, Soetedjo NNM, et al. Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus. The International Journal of Tuberculosis and Lung Disease. 2018;22: 1088–1094.10.5588/ijtld.17.082730092877Search in Google Scholar

5. Jain KK, Thakuria R, Lokesh S. Prevalence of pulmonary diabetes mellitus in tuberculosis patients attending tertiary care institute. International Medical Journal. 2015;2(4): 245–248.Search in Google Scholar

6. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, Van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health. 2010;12(11): 1289–1299.10.1111/j.1365-3156.2010.02625.x20955495Search in Google Scholar

7. Liu Q, Li W, Xue M, Chen Y, Du X, Wang C, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Scientific Reports. 2017;7: 1090.10.1038/s41598-017-01213-5543079728439071Search in Google Scholar

8. American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clinical Diabetes. 2019;37(1): 11–34.10.2337/cd18-0105633611930705493Search in Google Scholar

9. Semianiv I, Todoriko L, Ieremenchuk I. Prevention of adverse reactions due to pharmacotherapy in MRTB considering polymorphism of glutathione-S-transferase M1 and T1 genes. Europen Respiratory Journal. 2017;49: 60.Search in Google Scholar

10. Todoriko LD. Immunopathogenesis of drug-resistant tuberculosis present position. Tuberculosis Lung Disease HIV-Infection. 2017;3(30): 92–98.Search in Google Scholar

11. World Health Organization. Rapid Communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). August 2018. WHO/CDS/TB/2018.18.Search in Google Scholar